Skip to main content

Peer Review reports

From: Renoprotective effect of febuxostat on contrast-induced acute kidney injury in chronic kidney disease patients stage 3: randomized controlled trial

Original Submission
16 Sep 2022 Submitted Original manuscript
Resubmission - Version 2
Submitted Manuscript version 2
Resubmission - Version 3
Submitted Manuscript version 3
4 Nov 2022 Reviewed Reviewer Report
6 Nov 2022 Reviewed Reviewer Report
24 Nov 2022 Reviewed Reviewer Report
23 Dec 2022 Author responded Author comments - Nahla Teama
Resubmission - Version 4
23 Dec 2022 Submitted Manuscript version 4
27 Dec 2022 Author responded Author comments - Nahla Teama
Resubmission - Version 5
27 Dec 2022 Submitted Manuscript version 5
29 Dec 2022 Author responded Author comments - Nahla Teama
Resubmission - Version 6
29 Dec 2022 Submitted Manuscript version 6
15 Jan 2023 Reviewed Reviewer Report
14 Feb 2023 Author responded Author comments - Nahla Teama
Resubmission - Version 7
14 Feb 2023 Submitted Manuscript version 7
4 Mar 2023 Reviewed Reviewer Report
8 Mar 2023 Reviewed Reviewer Report
Resubmission - Version 8
Submitted Manuscript version 8
Publishing
9 Mar 2023 Editorially accepted
22 Mar 2023 Article published 10.1186/s12882-023-03114-4

You can find further information about peer review here.

Back to article page